Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CANAGLIFLOZIN Cause Peripheral ischaemia? 105 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 105 reports of Peripheral ischaemia have been filed in association with CANAGLIFLOZIN (INVOKANA). This represents 0.4% of all adverse event reports for CANAGLIFLOZIN.

105
Reports of Peripheral ischaemia with CANAGLIFLOZIN
0.4%
of all CANAGLIFLOZIN reports
4
Deaths
94
Hospitalizations

How Dangerous Is Peripheral ischaemia From CANAGLIFLOZIN?

Of the 105 reports, 4 (3.8%) resulted in death, 94 (89.5%) required hospitalization, and 5 (4.8%) were considered life-threatening.

Is Peripheral ischaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CANAGLIFLOZIN. However, 105 reports have been filed with the FAERS database.

What Other Side Effects Does CANAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,413) Toe amputation (2,193) Osteomyelitis (2,146) Acute kidney injury (1,853) Fungal infection (1,385) Gangrene (1,081) Weight decreased (1,014) Cellulitis (1,007) Urinary tract infection (920) Diabetic foot infection (832)

What Other Drugs Cause Peripheral ischaemia?

RIVAROXABAN (119) ASPIRIN (111) CARBOPLATIN (96) CISPLATIN (89) NOREPINEPHRINE (78) HEPARIN (76) EPINEPHRINE (68) GEMCITABINE (64) OXALIPLATIN (64) APIXABAN (62)

Which CANAGLIFLOZIN Alternatives Have Lower Peripheral ischaemia Risk?

CANAGLIFLOZIN vs CANAGLIFLOZIN\METFORMIN CANAGLIFLOZIN vs CANAKINUMAB CANAGLIFLOZIN vs CANDESARTAN CANAGLIFLOZIN vs CANDESARTAN CILEXETIL CANAGLIFLOZIN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE

Related Pages

CANAGLIFLOZIN Full Profile All Peripheral ischaemia Reports All Drugs Causing Peripheral ischaemia CANAGLIFLOZIN Demographics